These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12970175)

  • 41. Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells.
    Antonio V; Janvier B; Brouillet A; Andreani M; Raymondjean M
    Biochem J; 2003 Dec; 376(Pt 2):351-60. PubMed ID: 12882648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural basis of RXR-DNA interactions.
    Zhao Q; Chasse SA; Devarakonda S; Sierk ML; Ahvazi B; Rastinejad F
    J Mol Biol; 2000 Feb; 296(2):509-20. PubMed ID: 10669605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unliganded thyroid hormone receptor-beta1 represses liver X receptor alpha/oxysterol-dependent transactivation.
    Kawai K; Sasaki S; Morita H; Ito T; Suzuki S; Misawa H; Nakamura H
    Endocrinology; 2004 Dec; 145(12):5515-24. PubMed ID: 15319359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of fish oil feeding and fasting on LXRalpha/RXRalpha binding to LXRE in the SREBP-1c promoter in mouse liver.
    Nakatani T; Katsumata A; Miura S; Kamei Y; Ezaki O
    Biochim Biophys Acta; 2005 Sep; 1736(1):77-86. PubMed ID: 16112614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamical probing of allosteric control in nuclear receptors.
    Cunningham MA
    J Mol Model; 2012 Jul; 18(7):3147-52. PubMed ID: 22222612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationship of nuclear receptor-ligand interactions.
    Greschik H; Moras D
    Curr Top Med Chem; 2003; 3(14):1573-99. PubMed ID: 14683516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity.
    Musille PM; Kossmann BR; Kohn JA; Ivanov I; Ortlund EA
    J Biol Chem; 2016 Jan; 291(3):1411-26. PubMed ID: 26553876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying new liver X receptor alpha modulators and distinguishing between agonists and antagonists by crystal ligand pocket screening.
    Lee JH; Huang CF; Chuang YJ; Lee CY; Yu WH; Wu CC; Lin YT
    Future Med Chem; 2020 Jul; 12(13):1227-1237. PubMed ID: 32432891
    [No Abstract]   [Full Text] [Related]  

  • 51. The nuclear receptor ligand-binding domain: a family-based structure analysis.
    Folkertsma S; van Noort PI; Brandt RF; Bettler E; Vriend G; de Vlieg J
    Curr Med Chem; 2005; 12(9):1001-16. PubMed ID: 15892635
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Aida H; Morita R; Shigeta Y; Harada R
    Phys Chem Chem Phys; 2021 Sep; 23(36):20398-20405. PubMed ID: 34494045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The nuclear receptor ligand-binding domain: structure and function.
    Moras D; Gronemeyer H
    Curr Opin Cell Biol; 1998 Jun; 10(3):384-91. PubMed ID: 9640540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A structural perspective of liver X receptors.
    Gustafsson JÅ; Li XC; Suh JH; Lou X
    Vitam Horm; 2023; 123():231-247. PubMed ID: 37717986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ligand Pathways in Nuclear Receptors.
    Fischer A; Smieško M
    J Chem Inf Model; 2019 Jul; 59(7):3100-3109. PubMed ID: 31246455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical genomics of orphan nuclear receptors.
    Willson T
    Ernst Schering Res Found Workshop; 2003; (42):29-42. PubMed ID: 12664534
    [No Abstract]   [Full Text] [Related]  

  • 57. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.
    Fradera X; Vu D; Nimz O; Skene R; Hosfield D; Wynands R; Cooke AJ; Haunsø A; King A; Bennett DJ; McGuire R; Uitdehaag JC
    J Mol Biol; 2010 May; 399(1):120-32. PubMed ID: 20382159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha.
    Bourguet W; Ruff M; Chambon P; Gronemeyer H; Moras D
    Nature; 1995 Jun; 375(6530):377-82. PubMed ID: 7760929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist.
    Hoerer S; Schmid A; Heckel A; Budzinski RM; Nar H
    J Mol Biol; 2003 Dec; 334(5):853-61. PubMed ID: 14643652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver X receptors in lipid metabolism: opportunities for drug discovery.
    Hong C; Tontonoz P
    Nat Rev Drug Discov; 2014 Jun; 13(6):433-44. PubMed ID: 24833295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.